This article discusses recent research into biomarkers derived from smoking-related phenotypes, specifically Cotinine and carbon monoxide levels, to improve predictions of smoking cessation outcomes.
Understanding these biomarkers can help tailor more effective smoking cessation strategies and enhance public health efforts to reduce tobacco use.